I now have enough information to write a thorough, thesis-relevant summary. Let me compile it:
Summary of Menopausal Symptoms in Women (DC Dutta - Textbook of Gynecology, Chapter 6)
Prepared for Literature Review - Thesis: "An Observational Study to Evaluate Medoroga Lakshana in Menopausal Aged Women w.s.r. to Hyperlipidemia"
Department: Roga Nidana evum Vikriti Vigyana
1. Definition and Age
Menopause is defined as permanent cessation of menstruation at the end of reproductive life due to loss of ovarian follicular activity. The clinical diagnosis is confirmed after 12 consecutive months of amenorrhea without any pathological cause. The average age of menopause is 47-50 years (range: 45-55 years). The age is genetically predetermined and unrelated to age at menarche or number of pregnancies. Early menopause is associated with cigarette smoking, malnutrition, high altitude, chemotherapy, and ovarian resection.
2. Endocrine Changes Underlying Symptoms
With depletion of ovarian follicles:
- Serum FSH rises 10-20 fold; LH rises 3-fold
- Estradiol levels fall to < 20 pg/mL
- GnRH pulse secretion increases in frequency and amplitude
- Levels of inhibin and prolactin fall
- Adrenal DHEAS levels decline
The resulting estrogen deficiency is the root cause of most menopausal symptoms and metabolic complications.
3. Menopausal Symptoms - Classified
A. Menstrual Changes
- Shorter menstrual cycles (most common early feature)
- Irregular uterine bleeding (AUB) - due to anovulation and unopposed estrogen
- Progressive oligomenorrhea leading to amenorrhea
B. Vasomotor Symptoms (Characteristic Symptoms)
The hallmark of menopause is the hot flash - a sudden feeling of heat followed by profuse sweating. Specific features:
- Hot flashes with upper body and facial flushing
- Profuse sweating (night sweats)
- Palpitation
- Fatigue and weakness
- Sleep disturbance due to night sweats
- Duration: 1-10 minutes per episode
- Mechanism: Low estrogen lowers the threshold of the hypothalamic thermoregulatory zone; neurotransmitters norepinephrine and serotonin are involved
- Risk factors for severe vasomotor symptoms: surgical menopause, smoking, sedentary lifestyle, early menopause, use of SERMs, white ethnicity
C. Psychological / Neurological Changes
- Anxiety
- Headache
- Insomnia and sleep disturbances
- Irritability
- Mood swings
- Depression
- Poor memory and inability to concentrate
- Dysphasia (word-finding difficulty)
- Dementia and cognitive decline (estrogen improves cerebral perfusion and cognition)
D. Genitourinary Changes
- Vaginal dryness and atrophy - due to estradiol deficiency causing thinning of vaginal epithelium
- Dyspareunia (painful intercourse) - due to vaginal atrophy
- Decreased libido
- Minimal trauma causes vaginal bleeding
- Leukorrhea
- Dysuria (burning during urination)
- Urinary frequency and urgency
- Urge or stress incontinence
- Vaginal pH becomes alkaline (loss of Doderlein's bacillus)
E. Musculoskeletal Changes
- Osteoporosis - bone mass loss of 2-5% per year for the first 5-10 years after menopause, then slows to 1% per year
- Osteopenia (precursor to osteoporosis)
- Fractures - common sites: vertebra, femoral neck, wrist (Colles' fracture)
- Back pain, loss of height, kyphosis (vertebral involvement)
- Joint aches
- Backache
- Mechanism: Estrogen deficiency upregulates osteoclast activity via the RANK/RANK Ligand/Osteoprotegerin pathway
F. Cardiovascular and Metabolic Changes (Directly Relevant to Your Thesis)
- Hyperlipidemia - due to estrogen deficiency:
- Oxidation of LDL increases
- Foam cell formation causes vascular endothelial injury
- Smooth muscle proliferation in vessel walls
- Insulin resistance and central (android) obesity / weight gain - classical Medoroga feature
- Atherosclerosis - due to above lipid changes
- Vasoconstriction and thrombus formation
- Increased risk of ischemic heart disease, coronary artery disease and stroke (CVD risk higher than premenopausal women)
- Hypercoagulable state - due to rise in fibrinogen, plasminogen activator inhibitor, factor VII
- Gallbladder disease - increased incidence post-ERT due to rise in biliary cholesterol
- Impaired glucose tolerance (listed as cardiovascular risk factor)
- Familial hyperlipidemia is listed among CV risk factors
- Palpitations
G. Skin and Hair Changes
- Thinning and loss of elasticity of skin
- Wrinkling ('purse string' around mouth, 'crow feet' around eyes)
- Skin collagen decreases by 1-2% per year
- Loss of pubic and axillary hair
- Slight balding (due to low estrogen with relative androgen excess)
H. Pelvic Floor and Anatomical Changes
- Pelvic relaxation and uterine descent
- Narrowing of vaginal introitus
- Breast atrophy - breast fat reabsorbed, nipples decrease in size, breasts become flat and pendulous
4. Key Correlation with Your Thesis (Medoroga Lakshana and Hyperlipidemia)
From this source, the following symptoms occurring in menopausal women are directly correlated with Medoroga lakshana and can form the basis of your observational study:
| Symptom from DC Dutta | Medoroga Correlation |
|---|
| Central (android) obesity / weight gain | Sthaulya (obesity), Medo vriddhi |
| Hyperlipidemia (elevated LDL, lipid oxidation) | Medoroga (excess Meda dhatu) |
| Insulin resistance | Prameha purvarupa |
| Atherosclerosis / CVD risk | Medo-related srotodusti |
| Fatigue and heaviness | Alasya, Angagaurava |
| Sedentary predisposition | Avyayama, nidra |
| Sweating (diaphoresis) | Atisvedana (excess sweating - Medoroga lakshana) |
The text specifically states: "These women develop insulin resistance and central (android) obesity. All these lead to vascular atherosclerotic changes" - this directly maps to the Medoroga and its upadrava.
5. Source Citation
DC Dutta. Textbook of Gynecology (Chapter 6: Menopause). Pages 48-58.
Note for your literature review presentation: This chapter provides strong modern/contemporary evidence that menopausal women specifically develop dyslipidemia (elevated LDL, lipid peroxidation, foam cell formation), central obesity, and insulin resistance due to estrogen deficiency - all of which have direct parallels in Ayurvedic Medoroga pathophysiology. You can juxtapose this with Charaka/Sushruta references on Medoroga nidana and lakshana in your comparative analysis.